FineMark National Bank & Trust’s Chemours CC Stock Holding History

FineMark National Bank & Trust’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,043	Closed	-$45K	–	462
2016 Q4	$45K	Buy	2,043 +471	+30%	+$9.67K	﹤0.01%	645
2016 Q3	$25K	Sell	1,572 -145	-8%	-$1.66K	﹤0.01%	763
2016 Q2	$14K	Sell	1,717 -80	-4%	-$713	﹤0.01%	880
2016 Q1	$13K	Sell	1,797 -440	-20%	-$2.21K	﹤0.01%	849
2015 Q4	$12K	Sell	2,237 -635	-22%	-$4.06K	﹤0.01%	898
2015 Q3	$19K	Buy	+2,872	New	+$30.1K	﹤0.01%	854

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

FineMark National Bank & Trust's CC Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Chemours (CC) in Q1 2017, closing a stake of 2,043 shares — an estimated $45K sold.

FineMark National Bank & Trust first reported a position in CC in Q3 2015 and held it in 6 quarters. The position peaked at $45K in Q4 2016. 458 funds tracked by Wall St. Rank hold CC as of Q1 2017.

FineMark National Bank & Trust reported no remaining Chemours position as of Q1 2017 after selling out during the quarter.
FineMark National Bank & Trust sold 2,043 Chemours shares in Q1 2017, an estimated $45K.
FineMark National Bank & Trust first reported a position in Chemours in Q3 2015 and held it in 6 quarters.
FineMark National Bank & Trust's Chemours position peaked at $45K in Q4 2016.
458 funds tracked by Wall St. Rank held Chemours as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.